TrialEpilepsia open2022

Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal-onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open-label Study 342 (FREEDOM).

Ryan Edbert Husni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.